Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 130.12 M

Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow is USD 130.12 M for the year ending December 31, 2023, a -46.52% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 243.31 M, a 24.95% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 194.73 M, a -16.10% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 232.11 M, a 25.59% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 184.82 M, a 1.27% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities